Your account is not claimed yet. You can sign up with ORCID to claim your account.

Pilar López-Nieva

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

International journal of molecular sciences

Scientific reports

British journal of haematology

BMC cancer

Universidad Autonoma de Madrid Centro de Biología Molecular Severo Ochoa

Universidad Autonoma de Madrid Facultad de Ciencias (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Autonoma de Madrid Centro de Biología Molecular Severo Ochoa Jan 1o 2010

Spain

Investigador Postdoctoral :: Biología Celular e Inmunología

Education History

Universidad Autonoma de Madrid Facultad de Ciencias Apr 26o 2006

Spain

PHD :: Departamento de Biología

Publications

María Villa-Morales, Laura Pérez-Gómez, Eduardo Pérez-Gómez, Pilar López-Nieva, Pablo Fernández-Navarro, Javier Santos
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia. International journal of molecular sciences 24 (12) (2023)
Antonio Lahera, Laura Vela-Martín, Pilar López-Nieva, Rocío N Salgado, Sandra Rodríguez-Perales, Raul Torres-Ruíz, Jose Luis Lopez-Lorenzo, Javier Cornago, Pilar Llamas, Pablo Fernandez-Navarro, Rebeca Sánchez-Domínguez, José Carlos Segovia, Isabel Sastre, María Á Cobos-Fernández, Pablo Menéndez, Javier Santos, José Fernández-Piqueras, María Villa-Morales
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL. British journal of haematology (2023)
Antonio Lahera, Pilar López-Nieva, Hernán Alarcón, José Luis Marín-Rubio, María Á Cobos-Fernández, Pablo Fernandez-Navarro, Agustín Fernández Fernández, Laura Vela-Martín, Isabel Sastre, Sara Ruiz-García, Pilar Llamas, Jose Luis Lopez-Lorenzo, Javier Cornago, Javier Santos, José Fernández-Piqueras, María Villa-Morales
SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms. British journal of haematology (2023)
María Villa-Morales, Laura Pérez-Gómez, Eduardo Pérez-Gómez, Pilar López-Nieva, Pablo Fernández-Navarro, Javier Santos
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia. International journal of molecular sciences 24 (12) (2023)
María Villa-Morales, Laura Pérez-Gómez, Eduardo Pérez-Gómez, Pilar López-Nieva, Pablo Fernández-Navarro, Javier Santos
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia. International journal of molecular sciences 24 (12) (2023)
Pilar López-Nieva, Iria González-Vasconcellos, Laura González-Sánchez, María A Cobos-Fernández, Sara Ruiz-García, Raúl Sánchez Pérez, Ángel Aroca, José Fernández-Piqueras, Javier Santos
Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime. Scientific reports 12 (1) (2022)
Pilar López-Nieva, Pablo Fernandez-Navarro, María Ángeles Cobos-Fernández, Iria González-Vasconcellos, Raúl Sánchez Pérez, Ángel Aroca, José Fernández-Piqueras, Javier Santos
Patterns of Differentially Expressed circRNAs in Human Thymocytes. Non-coding RNA 8 (2) (2022)
Pilar López-Nieva, Laura González-Sánchez, María Ángeles Cobos-Fernández, Raúl Córdoba, Javier Santos, José Fernández-Piqueras
More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment. The oncologist 26 (2) (2020)
Pablo Fernandez-Navarro, Pilar López-Nieva, Elena Piñeiro-Yañez, Gonzalo Carreno-Tarragona, Joaquín Martinez-López, Raúl Sánchez Pérez, Ángel Aroca, Fátima Al-Shahrour, María Ángeles Cobos-Fernández, José Fernández-Piqueras
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data. BMC cancer 19 (1) (2019)
Pilar López-Nieva, Pablo Fernández-Navarro, Osvaldo Graña-Castro, Eduardo Andrés-León, Javier Santos, María Villa-Morales, María Ángeles Cobos-Fernández, Laura González-Sánchez, Marcos Malumbres, María Salazar-Roa, José Fernández-Piqueras
Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma. Scientific reports 9 (1) (2019)

Pilar López-Nieva.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pilar López-Nieva